What an incredible day! Thank you to our dedicated community of supporters who came together to rally for movement disorders research and education on Colorado Gives Day. As promised, every gift made during this campaign will be doubled through the generous support of our board of directors.

Best of all, Movement Disorders Foundation will continue to match contributions received this year - dollar for dollar - in our continuing commitment to supporting the most promising translational research and treatments to improve the quality of life for people with movement disorders. We need your support to ensure we can continue finding, assessing and supporting today's most innovative "undiscovered pioneers" in research.

Please support our efforts by giving during this special year-end match campaign and your tax-deductible gift will be DOUBLED. Click here and make twice the impact for MDF research and education. All gifts given up to $5,000 will be doubled through 11:59 P.M. MST on December 31.

Are you a patient or caregiver with something to say

Rare Patient Voice (RPV) connects patients and caregivers with the opportunity to voice their opinions through surveys and interviews to improve medical products and services, while earning cash rewards.

Click here to learn more. It’s free and RPV accepts both rare and non-rare diagnoses.

Rare Patient Voices in currently recruiting patients and caregivers living in Germany for an important Parkinson’s disease study.

This is a 60-minute web-assisted phone interview, and the compensation is EUR 110. Please sign up at the link above to receive an email invitation to a screening survey to see if you qualify. 

uniQure gets the green light to resume testing HD gene therapy

After patient enrollment was paused in the higher-dose level in the European phase 1/2 trial of AMT-130 (uniQure), a gene therapy in development for Huntington disease, uniQure announced that the trial’s Data Safety Monitoring Board (DSMB) has recommended that patient enrollment resume at this higher dose. Click here to learn more.

Role of supplementary motor area in cervical dystonia and sensory tricks

Sensory trick is a characteristic feature of cervical dystonia (CD), where a light touch on the area adjacent to the dystonia temporarily improves symptoms. Clinical benefit from sensory tricks can be observed before tactile contact is made or even by imagination. 

The supplementary motor area (SMA) may dynamically interact with the sensorimotor network and other brain regions during sensory tricks in patients with CD. Click here to learn more.

NE3107 plus levodopa leads to better motor gains

BioVie’s investigational oral therapy NE3107, taken in combination with standard levodopa, eases motor symptoms more substantially than levodopa alone in people with Parkinson’s disease, according to top-line results of a Phase 2 clinical trial. Click here to read more.